About Brett Ewald
Form D filings for Radionetics Oncology in 2023 list Brett Ewald as interim chief operating officer.
Brett Ewald first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Brett Ewald in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Brett Ewald works with at each company, as listed on that company's latest Form D.
Radionetics Oncology, Inc. · Form D, Aug 15, 2023
AS
Andrew Schwab
Director
UG
Umesh Gangadharmath
Executive officer
DE
Dan Estes
Executive officer and director
IM
Istvan Molnar
Executive officer
YZ
Yunfei Zhu
Executive officer
AK
Ana Kusnetzow
Executive officer
SS
Scott Struthers
Director